Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Sustained release excipients Market

ID: MRFR/HC/20477-HCR
128 Pages
Nidhi Mandole
Last Updated: April 06, 2026

Sustained Release Excipients Market Research Report Information By Product Type (Gelatin, Polymers, Minerals, Sugars, and Others), By Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, and Others), By Technology (Targeted Delivery, Microencapsulation, Wurster Technique, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Sustained release excipients Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product Type (USD Billion)
  49.     4.1.1 Gelatin
  50.     4.1.2 Polymers
  51.     4.1.3 Minerals
  52.     4.1.4 Sugars
  53.     4.1.5 Others
  54.   4.2 Healthcare, BY Route of Administration (USD Billion)
  55.     4.2.1 Oral
  56.     4.2.2 Intramuscular
  57.     4.2.3 Subcutaneous
  58.     4.2.4 Transdermal
  59.     4.2.5 Intravenous
  60.     4.2.6 Others
  61.   4.3 Healthcare, BY Technology (USD Billion)
  62.     4.3.1 Targeted Delivery
  63.     4.3.2 Microencapsulation
  64.     4.3.3 Wurster Technique
  65.     4.3.4 Others
  66.   4.4 Healthcare, BY Region (USD Billion)
  67.     4.4.1 North America
  68.       4.4.1.1 US
  69.       4.4.1.2 Canada
  70.     4.4.2 Europe
  71.       4.4.2.1 Germany
  72.       4.4.2.2 UK
  73.       4.4.2.3 France
  74.       4.4.2.4 Russia
  75.       4.4.2.5 Italy
  76.       4.4.2.6 Spain
  77.       4.4.2.7 Rest of Europe
  78.     4.4.3 APAC
  79.       4.4.3.1 China
  80.       4.4.3.2 India
  81.       4.4.3.3 Japan
  82.       4.4.3.4 South Korea
  83.       4.4.3.5 Malaysia
  84.       4.4.3.6 Thailand
  85.       4.4.3.7 Indonesia
  86.       4.4.3.8 Rest of APAC
  87.     4.4.4 South America
  88.       4.4.4.1 Brazil
  89.       4.4.4.2 Mexico
  90.       4.4.4.3 Argentina
  91.       4.4.4.4 Rest of South America
  92.     4.4.5 MEA
  93.       4.4.5.1 GCC Countries
  94.       4.4.5.2 South Africa
  95.       4.4.5.3 Rest of MEA
  96. 5 SECTION V: COMPETITIVE ANALYSIS
  97.   5.1 Competitive Landscape
  98.     5.1.1 Overview
  99.     5.1.2 Competitive Analysis
  100.     5.1.3 Market share Analysis
  101.     5.1.4 Major Growth Strategy in the Healthcare
  102.     5.1.5 Competitive Benchmarking
  103.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  104.     5.1.7 Key developments and growth strategies
  105.       5.1.7.1 New Product Launch/Service Deployment
  106.       5.1.7.2 Merger & Acquisitions
  107.       5.1.7.3 Joint Ventures
  108.     5.1.8 Major Players Financial Matrix
  109.       5.1.8.1 Sales and Operating Income
  110.       5.1.8.2 Major Players R&D Expenditure. 2023
  111.   5.2 Company Profiles
  112.     5.2.1 BASF SE (DE)
  113.       5.2.1.1 Financial Overview
  114.       5.2.1.2 Products Offered
  115.       5.2.1.3 Key Developments
  116.       5.2.1.4 SWOT Analysis
  117.       5.2.1.5 Key Strategies
  118.     5.2.2 Evonik Industries AG (DE)
  119.       5.2.2.1 Financial Overview
  120.       5.2.2.2 Products Offered
  121.       5.2.2.3 Key Developments
  122.       5.2.2.4 SWOT Analysis
  123.       5.2.2.5 Key Strategies
  124.     5.2.3 Ashland Global Holdings Inc. (US)
  125.       5.2.3.1 Financial Overview
  126.       5.2.3.2 Products Offered
  127.       5.2.3.3 Key Developments
  128.       5.2.3.4 SWOT Analysis
  129.       5.2.3.5 Key Strategies
  130.     5.2.4 Dow Inc. (US)
  131.       5.2.4.1 Financial Overview
  132.       5.2.4.2 Products Offered
  133.       5.2.4.3 Key Developments
  134.       5.2.4.4 SWOT Analysis
  135.       5.2.4.5 Key Strategies
  136.     5.2.5 JRS Pharma (DE)
  137.       5.2.5.1 Financial Overview
  138.       5.2.5.2 Products Offered
  139.       5.2.5.3 Key Developments
  140.       5.2.5.4 SWOT Analysis
  141.       5.2.5.5 Key Strategies
  142.     5.2.6 Colorcon Inc. (US)
  143.       5.2.6.1 Financial Overview
  144.       5.2.6.2 Products Offered
  145.       5.2.6.3 Key Developments
  146.       5.2.6.4 SWOT Analysis
  147.       5.2.6.5 Key Strategies
  148.     5.2.7 FMC Corporation (US)
  149.       5.2.7.1 Financial Overview
  150.       5.2.7.2 Products Offered
  151.       5.2.7.3 Key Developments
  152.       5.2.7.4 SWOT Analysis
  153.       5.2.7.5 Key Strategies
  154.     5.2.8 Gattefossé (FR)
  155.       5.2.8.1 Financial Overview
  156.       5.2.8.2 Products Offered
  157.       5.2.8.3 Key Developments
  158.       5.2.8.4 SWOT Analysis
  159.       5.2.8.5 Key Strategies
  160.     5.2.9 Merck KGaA (DE)
  161.       5.2.9.1 Financial Overview
  162.       5.2.9.2 Products Offered
  163.       5.2.9.3 Key Developments
  164.       5.2.9.4 SWOT Analysis
  165.       5.2.9.5 Key Strategies
  166.     5.2.10 Shin-Etsu Chemical Co., Ltd. (JP)
  167.       5.2.10.1 Financial Overview
  168.       5.2.10.2 Products Offered
  169.       5.2.10.3 Key Developments
  170.       5.2.10.4 SWOT Analysis
  171.       5.2.10.5 Key Strategies
  172.   5.3 Appendix
  173.     5.3.1 References
  174.     5.3.2 Related Reports
  175. 6 LIST OF FIGURES
  176.   6.1 MARKET SYNOPSIS
  177.   6.2 NORTH AMERICA MARKET ANALYSIS
  178.   6.3 US MARKET ANALYSIS BY PRODUCT TYPE
  179.   6.4 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  180.   6.5 US MARKET ANALYSIS BY TECHNOLOGY
  181.   6.6 CANADA MARKET ANALYSIS BY PRODUCT TYPE
  182.   6.7 CANADA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  183.   6.8 CANADA MARKET ANALYSIS BY TECHNOLOGY
  184.   6.9 EUROPE MARKET ANALYSIS
  185.   6.10 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
  186.   6.11 GERMANY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  187.   6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY
  188.   6.13 UK MARKET ANALYSIS BY PRODUCT TYPE
  189.   6.14 UK MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  190.   6.15 UK MARKET ANALYSIS BY TECHNOLOGY
  191.   6.16 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
  192.   6.17 FRANCE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  193.   6.18 FRANCE MARKET ANALYSIS BY TECHNOLOGY
  194.   6.19 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
  195.   6.20 RUSSIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  196.   6.21 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
  197.   6.22 ITALY MARKET ANALYSIS BY PRODUCT TYPE
  198.   6.23 ITALY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  199.   6.24 ITALY MARKET ANALYSIS BY TECHNOLOGY
  200.   6.25 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
  201.   6.26 SPAIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  202.   6.27 SPAIN MARKET ANALYSIS BY TECHNOLOGY
  203.   6.28 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
  204.   6.29 REST OF EUROPE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  205.   6.30 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
  206.   6.31 APAC MARKET ANALYSIS
  207.   6.32 CHINA MARKET ANALYSIS BY PRODUCT TYPE
  208.   6.33 CHINA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  209.   6.34 CHINA MARKET ANALYSIS BY TECHNOLOGY
  210.   6.35 INDIA MARKET ANALYSIS BY PRODUCT TYPE
  211.   6.36 INDIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  212.   6.37 INDIA MARKET ANALYSIS BY TECHNOLOGY
  213.   6.38 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
  214.   6.39 JAPAN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  215.   6.40 JAPAN MARKET ANALYSIS BY TECHNOLOGY
  216.   6.41 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
  217.   6.42 SOUTH KOREA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  218.   6.43 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
  219.   6.44 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
  220.   6.45 MALAYSIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  221.   6.46 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
  222.   6.47 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
  223.   6.48 THAILAND MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  224.   6.49 THAILAND MARKET ANALYSIS BY TECHNOLOGY
  225.   6.50 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
  226.   6.51 INDONESIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  227.   6.52 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
  228.   6.53 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
  229.   6.54 REST OF APAC MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  230.   6.55 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
  231.   6.56 SOUTH AMERICA MARKET ANALYSIS
  232.   6.57 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
  233.   6.58 BRAZIL MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  234.   6.59 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
  235.   6.60 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
  236.   6.61 MEXICO MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  237.   6.62 MEXICO MARKET ANALYSIS BY TECHNOLOGY
  238.   6.63 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
  239.   6.64 ARGENTINA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  240.   6.65 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
  241.   6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
  242.   6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  243.   6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
  244.   6.69 MEA MARKET ANALYSIS
  245.   6.70 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
  246.   6.71 GCC COUNTRIES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  247.   6.72 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
  248.   6.73 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
  249.   6.74 SOUTH AFRICA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  250.   6.75 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
  251.   6.76 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
  252.   6.77 REST OF MEA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  253.   6.78 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
  254.   6.79 KEY BUYING CRITERIA OF HEALTHCARE
  255.   6.80 RESEARCH PROCESS OF MRFR
  256.   6.81 DRO ANALYSIS OF HEALTHCARE
  257.   6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  258.   6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  259.   6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
  260.   6.85 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  261.   6.86 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  262.   6.87 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
  263.   6.88 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
  264.   6.89 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  265.   6.90 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  266.   6.91 BENCHMARKING OF MAJOR COMPETITORS
  267. 7 LIST OF TABLES
  268.   7.1 LIST OF ASSUMPTIONS
  269.     7.1.1
  270.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  271.     7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  272.     7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  273.     7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  274.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  275.     7.3.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  276.     7.3.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  277.     7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  278.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  279.     7.4.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  280.     7.4.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  281.     7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  282.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  283.     7.5.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  284.     7.5.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  285.     7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  286.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  287.     7.6.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  288.     7.6.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  289.     7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  290.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  291.     7.7.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  292.     7.7.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  293.     7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  294.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  295.     7.8.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  296.     7.8.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  297.     7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  298.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  299.     7.9.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  300.     7.9.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  301.     7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  302.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  303.     7.10.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  304.     7.10.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  305.     7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  306.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  307.     7.11.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  308.     7.11.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  309.     7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  310.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  311.     7.12.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  312.     7.12.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  313.     7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  314.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  315.     7.13.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  316.     7.13.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  317.     7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  318.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  319.     7.14.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  320.     7.14.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  321.     7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  322.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  323.     7.15.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  324.     7.15.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  325.     7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  326.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  327.     7.16.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  328.     7.16.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  329.     7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  330.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  331.     7.17.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  332.     7.17.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  333.     7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  334.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  335.     7.18.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  336.     7.18.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  337.     7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  338.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  339.     7.19.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  340.     7.19.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  341.     7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  342.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  343.     7.20.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  344.     7.20.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  345.     7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  346.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  347.     7.21.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  348.     7.21.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  349.     7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  350.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  351.     7.22.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  352.     7.22.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  353.     7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  354.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  355.     7.23.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  356.     7.23.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  357.     7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  358.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  359.     7.24.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  360.     7.24.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  361.     7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  362.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  363.     7.25.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  364.     7.25.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  365.     7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  366.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  367.     7.26.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  368.     7.26.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  369.     7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  370.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  371.     7.27.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  372.     7.27.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  373.     7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  374.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  375.     7.28.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  376.     7.28.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  377.     7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  378.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  379.     7.29.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  380.     7.29.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  381.     7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  382.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  383.     7.30.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  384.     7.30.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  385.     7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  386.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  387.     7.31.1
  388.   7.32 ACQUISITION/PARTNERSHIP
  389.     7.32.1

Healthcare Market Segmentation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Gelatin
  • Polymers
  • Minerals
  • Sugars
  • Others

Healthcare By Route of Administration (USD Billion, 2025-2035)

  • Oral
  • Intramuscular
  • Subcutaneous
  • Transdermal
  • Intravenous
  • Others

Healthcare By Technology (USD Billion, 2025-2035)

  • Targeted Delivery
  • Microencapsulation
  • Wurster Technique
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions